1.
研究组和对照组引产指征比较
Indications of for induction in the participants
| Indications | Oxytocin (n=957) | Controlled-release dinoprostone insert (n=1390) | p* |
| *Data are analyzed by one-way χ2 test. One mater may induced for multiple indications. #Other includes stillbirth, sever malformation fetus, intrauterine growth restriction, metal autoimmune disease. | |||
| Premature rupture of membranes | 530 (55.38%) | 91 (6.55%) | 0.000 |
| Prolonged pregnancy | 345 (36.05%) | 717 (51.58%) | 0.000 |
| Oligohydramnios | 121 (12.64%) | 487 (35.04%) | 0.000 |
| Gestational diabetes mellitus | 131 (13.69%) | 192(13.81%) | 0.932 |
| Polyhydramnios | 36 (3.76%) | 43 (3.09%) | 0.378 |
| Hypertensive disorders complicating pregnancy | 21(2.19%) | 60 (4.32%) | 0.006 |
| Metal psychological and social factors | 25 (2.61%) | 49 (3.53%) | 0.214 |
| Suspicious fetal distress | 18 (1.57%) | 26 (1.87%) | 0.985 |
| Other# | 13 (1.36%) | 32 (2.30%) | 0.101 |